Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has pioneered an enabling technology that enhances the body’s absorption of cannabinoids.
Marijuana Industry
PotNetwork Holding, Inc. (POTN) Subsidiary Reports Revenues in Excess of $1.6M for November
PotNetwork Holding, Inc. (OTC: POTN), through wholly-owned subsidiary Diamond CBD, Inc., this morning reported revenues exceeding $1.6 million for the month of November.
Purified Cannabinoids Open New Opportunities in Pain Management
In Canada, chronic pain affects 1.5 million people. As national and worldwide numbers in pain diagnoses continue to rise, innovators in the cannabis industry are developing promising therapies to address this growing market.
Medical Cannabis Payment Solutions (REFG) Integrates Cryptocurrency Payment Options
Medical Cannabis Payment Solutions (OTC: REFG) announced that it will integrate First Bitcoin cryptocurrency (“$Weed”) with its StateSourced medical cannabis payment gateway service.
Marijuana Company of America (MCOA) Subsidiary Poised for Breakthrough with CBD-based Wellness Products
Marijuana Company of America, Inc. (OTC: MCOA), via its wholly-owned subsidiary hempSMART, is well positioned to take advantage of this industry growth through the development and marketing of innovative hemp-derived, CBD-based nutritional and wellness products.
Cultivating the Cannabis Lifestyle: Canadian Cannabis Players Gear Up for Recreational Marijuana Legalization
The turning tide in public sentiment and the advancement of legalization, both in Canada and throughout the world, are gradually destigmatizing marijuana use and giving rise to new cannabis subcultures and brands.
Skinvisible, Inc. (SKVI) Maximizes Product Development Opportunities with Global Goals
Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI), continues to add significant value to its core business model with several key movements involving a proposed merger, new licensing agreements and formation of a specialized subsidiary.
BBC Capital - Meet Canada’s ‘weed sommelier’
Rade Kovacevic is a cannabis connoisseur. As the head of customer experience at Canopy Growth Corporation, a cannabis producer in Ontario, Canada, his job is to make sure his firm provides the highest quality marijuana. His company produces medicinal cannabis for patients across Canada, where recreational use is illegal but doctors can prescribe it to patients for medical purposes, such as pain management.
Global Payout, Inc.’s (GOHE) MTRAC Subsidiary Forms Key Partnership for Sales and Marketing Support
Global Payout (OTC: GOHE) announced today that its majority-owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”) has established a strategic partnership with T&T Financial.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Partners with Stakeholders to Participate on Global Scale with DehydraTECH™
Amidst increasing awareness regarding cannabinoids and their potential health benefits, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is at the forefront of the booming cannabis industry with its patented delivery technology, DehydraTECH™.
Companies Offer Intriguing Investment Opportunities as Bitcoin Continues Smashing Records
Various enterprising companies emerging within the marketplace are providing promising ancillary investment options for those seeking to cash in on bitcoin’s rising star without investing directly in it.
Study: U.S. Marijuana Legalization Would Create a Million New Jobs, $132 Billion in Tax Revenue in First 8 Years - From Washington Post
Legalizing marijuana nationwide would create at least $132 billion in tax revenue and more than a million new jobs across the United States in the next decade, according to a new study.
Biotech M&A Momentum Attractive for Cannabinoid R&D Space
With growing interest in the convergence of cannabis and medicine, companies like InMed Pharmaceuticals may find themselves on the radar of Big Pharma.
Marijuana Company of America (MCOA) Delivers Distinctive Cannabis Investment Opportunities
Marijuana Company of America (OTC: MCOA) is a distinctive corporation utilizing a strategic business structure within this burgeoning industry.
Biotechs Develop Proprietary Systems to Drive CBD Research and Development
With a market that’s expected to grow from $2 billion in 2020 to $50 billion in only nine years, according to Statista, biotechnology companies are increasingly focused on the development of proprietary systems and procedures to drive research and production of cannabinoid pharmaceuticals.